NKGen Biotech, Inc. (NKGN)

OTCMKTS · Delayed Price · Currency is USD

0.200

+0.010 (16.67%)

Mar 6, 2026, 9:30 AM EST

NKGen Biotech Employees

NKGen Biotech had 26 employees as of December 31, 2024. The number of employees decreased by 37 or -58.73% compared to the previous year.

Employees

26

Change (1Y)

-37

Growth (1Y)

-58.73%

Revenue / Employee

n/a

Profits / Employee

-$905,923

Market Cap

26.12M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	26	-37	-58.73%
Dec 31, 2023	63	-	-

Related Stocks

Company Name	Employees
Provectus Biopharmaceuticals	6
Harvard Apparatus Regenerative Technology	8
Finch Therapeutics Group	1
Oncotelic Therapeutics	26
Anebulo Pharmaceuticals	3
Inhibitor Therapeutics	9
ZIVO Bioscience	7
Zeo ScientifiX	20

Employee Rankings

NKGen Biotech News

6 weeks ago - NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. - GlobeNewsWire
5 months ago - NKGen Biotech Provides Clarification on Quotation Display and Trading Status on the OTC Expert Market - GlobeNewsWire
5 months ago - NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the XXVII World Congress of Neurology - GlobeNewsWire
6 months ago - NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum - GlobeNewsWire
6 months ago - NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets - GlobeNewsWire
7 months ago - NKGen Biotech To Present on Allogeneic Enhanced NK Cells without Lymphodepletion in Solid Tumors at the 13th Annual Immuno-Oncology Summit - GlobeNewsWire
8 months ago - NKGen Biotech Presents Troculeucel Mechanism of Action with Corresponding Phase 1 Biomarker Data at the Alzheimer's Association International Conference 2025 - GlobeNewsWire
8 months ago - NKGen Biotech to Present at the Alzheimer's Association International Conference 2025 - GlobeNewsWire